Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Burcon Nutrascience ( (TSE:BU) ) has provided an announcement.
Burcon NutraScience has upsized its non-brokered private placement of convertible debentures to an aggregate principal amount of up to $6.9 million, citing strong investor demand despite challenging market conditions. Insiders and the company’s manufacturing partner owners have committed to subscribe for at least $5 million of the offering, which has received conditional approval from the Toronto Stock Exchange and is expected to support accelerated production and sales efforts as Burcon pursues a revenue target of more than $10 million in 2026.
The most recent analyst rating on (TSE:BU) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Burcon Nutrascience stock, see the TSE:BU Stock Forecast page.
Spark’s Take on TSE:BU Stock
According to Spark, TipRanks’ AI Analyst, TSE:BU is a Neutral.
The score is held down primarily by very weak financial performance—severe unprofitability, continued cash burn, and a highly strained balance sheet with extremely high leverage. Technicals are modestly weak with the stock trading below key longer-term moving averages, while valuation is also pressured by negative earnings and no dividend data.
To see Spark’s full report on TSE:BU stock, click here.
More about Burcon Nutrascience
Burcon NutraScience is a global technology leader in high-performance plant-based proteins for the food and beverage industry, developing commercial ingredients with enhanced taste, texture and functionality for next-generation protein applications. With more than two decades of innovation and an extensive patent portfolio covering proteins from pea, canola, soy, hemp, sunflower and other plant sources, the company targets the rapidly expanding plant-based market with a focus on sustainable, best-in-class protein solutions.
Average Trading Volume: 9,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$21.95M
For an in-depth examination of BU stock, go to TipRanks’ Overview page.